Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
Zhiyuan MaMahesh KrishnamurthyPublished in: PloS one (2023)
Our results suggest that there is a significant association between the reduction of in-hospital mortality and outpatient metformin therapy for type 2 diabetes mellitus in patients hospitalized for COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- systematic review
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- type diabetes
- coronary artery disease
- risk factors
- meta analyses
- respiratory syndrome coronavirus
- skeletal muscle
- cardiovascular risk factors
- glycemic control